Andreia Sofia Barros concluded her Ph.D. in Biomedical Sciences at the University of Porto in 2024, under a collaboration with Ferring Pharmaceuticals, and is currently a Junior Postdoctoral Researcher at Instituto de Investigação e Inovação em Saúde (i3S). During her PhD, Sofia worked with smart nanosystems to target Inflammatory Bowel Disease, and with complex in vitro 3D models simulating the in vivo intestinal scenarios to use as drug screens and to study the pathology of some diseases. Over the years, Andreia has collaborated with prominent pharmaceutical partners and engaged in extensive training at leading institutions. Her research interest comprises the areas of biomaterials, tissue engineering, nanotechnology, and target intestinal delivery, resulting in multiple high-impact publications and presentations at international conferences. To date, Andreia Sofia published 9 peer-reviewed papers (first author and co-author), 1 book chapter, and presented her work in national and international meetings and conferences. Her work was recognized through several prizes, including the prestigious 2024 Young Scientist Investigator Trainee Award from the Controlled Release Society (CRS). Andreia is also deeply involved in professional societies like the CRS, where she actively contributes as a Young Scientist representative and participates in peer review and conference organization. Overall, Andreia Sofia is a young member of the scientific world, always engaging in several activities and important roles (PhD students representative, Young Scientists representative, and science ambassador), aiming to fight for good and better science quality.